Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Urology|December 20, 2014
Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancerHuei-Ting Tsai, Nancy L Keating, Stephen K Van Den Eeden, et al.
Environmental Health Perspectives|July 9, 2004
Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, IndiaSoma R Mitra, D N Guha Mazumder, Arindam Basu, et al.
Journal of the National Cancer Institute|December 4, 2015
Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer SurvivorsReina Haque, Jiaxiao Shi, Joanne E Schottinger, et al.
The Prostate|May 11, 2013
Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer studySheila Weinmann, Stephen K Van Den Eeden, Reina Haque, et al.
Breast Cancer Research : BCR|November 20, 2009
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community settingLaurel A Habel, Ninah S Achacoso, Reina Haque, et al.
Breast Cancer Research and Treatment|March 23, 2016
Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifenMarilyn L Kwan, Jiaxiao M Shi, Laurel A Habel, et al.
Epidemiology (Cambridge, Mass.)|February 28, 2003
Arsenic in drinking water and skin lesions: dose-response data from West Bengal, IndiaReina Haque, D N Guha Mazumder, Sambit Samanta, et al.
Medical Care|March 14, 2015
A hybrid approach to identify subsequent breast cancer using pathology and automated health information dataReina Haque, Jiaxiao Shi, Joanne E Schottinger, et al.
Springerplus|January 28, 2015
Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plansHeather Spencer Feigelson, Nikki M Carroll, Sheila Weinmann, et al.
Gynecologic Oncology|March 9, 2020
Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutationsReina Haque, Steven J Skates, Mary Anne Armstrong, et al.
Pageof 11